These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16548926)

  • 1. Competing accounts of the gateway effect: the field thins, but still no clear winner.
    Maccoun RJ
    Addiction; 2006 Apr; 101(4):473-4; discussion 474-6. PubMed ID: 16548926
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissecting the causal anatomy of the link between cannabis and other illicit drugs.
    Hall W
    Addiction; 2006 Apr; 101(4):472-3; discussion 474-6. PubMed ID: 16548925
    [No Abstract]   [Full Text] [Related]  

  • 3. Testing the Gateway Hypothesis.
    Kandel DB; Yamaguchi K; Klein LC
    Addiction; 2006 Apr; 101(4):470-2; discussion 474-6. PubMed ID: 16548924
    [No Abstract]   [Full Text] [Related]  

  • 4. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis.
    Fergusson DM; Boden JM; Horwood LJ
    Addiction; 2006 Apr; 101(4):556-69. PubMed ID: 16548935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the association between adolescent marijuana use and later serious drug use: gateway effect or developmental trajectory?
    Cleveland HH; Wiebe RP
    Dev Psychopathol; 2008; 20(2):615-32. PubMed ID: 18423097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative model is feasible, but the gateway hypothesis has not been invalidated: comments on Morral et al.
    Lynskey M
    Addiction; 2002 Dec; 97(12):1505-7. PubMed ID: 12472632
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence does not favor marijuana gateway effects over a common-factor interpretation of drug use initiation: responses to Anthony, Kenkel & Mathios and Lynskey.
    Morral AR; McCafrey DF; Paddock SM
    Addiction; 2002 Dec; 97(12):1509-10. PubMed ID: 12472633
    [No Abstract]   [Full Text] [Related]  

  • 8. Extensions to the modeling of initiation and progression: applications to substance use and abuse.
    Neale MC; Harvey E; Maes HH; Sullivan PF; Kendler KS
    Behav Genet; 2006 Jul; 36(4):507-24. PubMed ID: 16770695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Gateway effects': insights from economics are needed.
    Kenkel DS; Mathios AD
    Addiction; 2002 Dec; 97(12):1505. PubMed ID: 12472630
    [No Abstract]   [Full Text] [Related]  

  • 10. Reassessing the marijuana gateway effect.
    Morral AR; McCaffrey DF; Paddock SM
    Addiction; 2002 Dec; 97(12):1493-504. PubMed ID: 12472629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug abuse: vulnerability and transition to addiction.
    Le Moal M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S42-55. PubMed ID: 19434555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of physiological reactivity and perceived coping to substance use disorders.
    Bobadilla L; Taylor J
    Addict Behav; 2007 Mar; 32(3):608-16. PubMed ID: 16879927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for increased substance use in psychosis.
    Gregg L; Barrowclough C; Haddock G
    Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death of the 'stepping-stone' hypothesis and the 'gateway' model? Comments on Morral et al.
    Anthony JC
    Addiction; 2002 Dec; 97(12):1505-7. PubMed ID: 12472631
    [No Abstract]   [Full Text] [Related]  

  • 15. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins.
    Agrawal A; Lynskey MT; Bucholz KK; Martin NG; Madden PA; Heath AC
    Psychol Med; 2007 Jan; 37(1):49-60. PubMed ID: 17076916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the receptivity of substance abuse prevention programming affected by students' perceptions of the instructor?
    Stephens PC; Sloboda Z; Grey S; Stephens R; Hammond A; Hawthorne R; Teasdale B; Williams J
    Health Educ Behav; 2009 Aug; 36(4):724-45. PubMed ID: 18809689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early exposure to marijuana and risk of later drug use.
    Schier JG; Nelson LS; Hoffman RS
    JAMA; 2003 Jul; 290(3):329; author reply 330-1. PubMed ID: 12865368
    [No Abstract]   [Full Text] [Related]  

  • 19. Early exposure to marijuana and risk of later drug use.
    Macleod J; Hickman M; Smith GD
    JAMA; 2003 Jul; 290(3):329-30; author reply 330-1. PubMed ID: 12865367
    [No Abstract]   [Full Text] [Related]  

  • 20. Methodological issues in the assessment of substance use phenotypes.
    Neale MC; Aggen SH; Maes HH; Kubarych TS; Schmitt JE
    Addict Behav; 2006 Jun; 31(6):1010-34. PubMed ID: 16723188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.